Welcome words on behalf of the Organizing Committee
Why can up to 77% of all adverse drug reactions be prevented, yet they remain the 4th to 5th leading causes of death in Western countries?
How is it that safety risks in the nuclear and aeronautic industries can be perfectly managed, yet the healthcare industry still lags far behind?
ISOP ISRAEL answer: a multidisciplinary and solution-oriented symposium.
ISOP ISRAEL, whose purpose is to improve medication safety, proposes in this conference to discover ways to analyses, prevent and manage medication errors. This multidisciplinary symposium is solution-oriented: empowering human factors through risk communication and risk management approaches, and using artificial intelligence to analyse real world data. ISOP ISRAEL has gathered a dream team with the internationally renowned experts to deliver lectures at the forefront of patient safety. You will go back with a toolbox and methods that you can implement in your environment, the very day your return home...
A case study to test our new methodology: anticoagulants.
Welcome to ISOP ISRAEL 2019!
I would like to welcome you to the International Society of Pharmaco-vigilance (ISOP). I’m confident in your ability to develop and strengthen an efficient system of Risk Management. We have to promote and protect public health and the collaboration with Israel is indeed a wonderful added value.
As the president of ISOP, you know that I have always supported the creation of the ISoP Israel chapter and will continue to do so as President of CIOMS. I would like to thanks very much and to pay a tribute to my friend Rina-Irene. She is one of the pillars of the society and I’m happy that she accepted to take the lead of the Israel chapter.
I wish you a fruitful meeting.
Prof Hervé Le Louët
President of CIOMS, Symposium Chairman
Chair of the Scientific Committee
Building on deep roots to reach far into the future is Israel’s expertise. From theory to a case study, you will learn how hospitals, community-based pharmacies, industry (and more) have implemented methods and tools to decrease the risks and side effects of anticoagulant use. Working on this particular high-risk medication, we have build a team, a culture and a methodology that is easily transferable to other high-risk medications.
The Institute for Safe Medication Practices (ISMP), USA, has been working for 35 years in close collaboration with the US Food and Drug Administration (FDA) to prevent medication errors. ISMP Self Assessment tools are the backbone of our strategy implemented in several hospitals.
Pharmaceutical Society of Israel, Clinical Pharmacologists, Carmel and Mayanei HaYeshua hospitals, Alliance for Patient Safety, King's College of London and Hebrew University of Jerusalem, Centre for Medicine in Public Interest and Israeli Ministry of Health, and many other entities from other disciplines are supporting this symposium and ISOP ISRAEL activities.
We welcome those dedicated to improve medication safety: health care professionals, health care services (kupot kholim) patients, risk managers, academics, industry, regulatory authorities, IT software providers, and hospital managers, among many others. You will have the opportunity to meet and discuss common problems and learn about innovative solutions to medication safety problems.
We hope that you will enjoy our warm hospitality: within small distances, you will discover vibrant Tel Aviv, which never sleeps, the Mediterranean shores, inspiring Jerusalem, and the incredible Dead Sea colors embedded in the desert.
In Israel, multiculturalism is built on common roots and expressed with vitality, creativity and contrasts, in art, architecture, medicine, high tech and biotech.
Dr Rina-Irene Fermont
ISOP ISRAEL Chairman